Drugmakers including Pfizer Inc , GlaxoSmithKline PLC and Sanofi SA are planning to hike prices on more than 200 drugs in the United States on Wednesday, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors. Nearly all of the price increases will be below 10%, and around half of them are in the range of 4 to 6%, 3 Axis co-founder Eric Pachman said. More price increases are expected to be announced later this week, which could affect the median and range. …read more
Source:: Yahoo Finance
